RARE in the 13F filings
Ultragenyx Pharmaceutical In · CUSIP 90400D108
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 27
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 5 listed it in both
- Shares listed
- 20,093,390
- combined, among listed positions
- Reported value
- $664m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 11 buyers (opened or added shares) and 17 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -2,209,043.
Managers listing RARE in Q2 2026
27 of 27 holders
Largest increases and reductions, by shares
Increases
- AQR Capital Management LLCexisting position · 6,560,809 shares now+1,982,785
- Two Sigma Investments LPexisting position · 3,621,200 shares now+1,415,380
- T. Rowe Price Associates Incexisting position · 1,356,501 shares now+552,392
- D. E. Shaw & Co.existing position · 1,730,193 shares now+469,175
- Fidelity (FMR LLC)existing position · 576,849 shares now+289,533
Reductions
- Citadel Advisors LLCexisting position · 210,531 shares now-1,904,960
- Wellington Management Group LLPexisting position · 1,250,464 shares now-1,390,348
- Millennium Management LLCexisting position · 760,825 shares now-1,011,359
- Schonfeld Strategic Advisors LLCexisting position · 52,881 shares now-441,856
- Susquehanna International Group LLPexisting position · 180,871 shares now-343,927
New positions and exits
New (2)
Exited (4)
- Point72 Asset Management LPwas $19m
- Balyasny Asset Management LLCwas $8.1m
- Jane Street Group LLCwas $3.6m
- Tudor Investment Corpwas $1.1m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2014 | 2 | $108m | n.a. | n.a. |
| Q2 2014 | 2 | $103m | n.a. | n.a. |
| Q3 2014 | 2 | $237m | n.a. | n.a. |
| Q4 2014 | 2 | $187m | n.a. | n.a. |
| Q1 2015 | 6 | $676m | n.a. | n.a. |
| Q2 2015 | 7 | $1.2bn | n.a. | n.a. |
| Q3 2015 | 9 | $1.3bn | n.a. | n.a. |
| Q4 2015 | 9 | $1.7bn | n.a. | n.a. |
| Q1 2016 | 3 | $933m | n.a. | n.a. |
| Q2 2016 | 4 | $461m | n.a. | n.a. |
| Q3 2016 | 6 | $1.1bn | n.a. | n.a. |
| Q4 2016 | 5 | $1.2bn | n.a. | n.a. |
| Q1 2017 | 5 | $1.1bn | n.a. | n.a. |
| Q2 2017 | 3 | $661m | n.a. | n.a. |
| Q3 2017 | 3 | $505m | n.a. | n.a. |
| Q4 2017 | 5 | $532m | n.a. | n.a. |
| Q1 2018 | 6 | $655m | n.a. | n.a. |
| Q2 2018 | 6 | $1.3bn | n.a. | n.a. |
| Q3 2018 | 6 | $1.3bn | n.a. | n.a. |
| Q4 2018 | 6 | $598m | n.a. | n.a. |
| Q1 2019 | 7 | $1.3bn | n.a. | n.a. |
| Q2 2019 | 7 | $1.3bn | n.a. | n.a. |
| Q3 2019 | 6 | $767m | n.a. | n.a. |
| Q4 2019 | 6 | $685m | n.a. | n.a. |
| Q1 2020 | 6 | $791m | n.a. | n.a. |
| Q2 2020 | 5 | $1.5bn | n.a. | n.a. |
| Q3 2020 | 6 | $1.6bn | n.a. | n.a. |
| Q4 2020 | 8 | $3.0bn | n.a. | n.a. |
| Q1 2021 | 10 | $2.6bn | n.a. | n.a. |
| Q2 2021 | 14 | $2.3bn | n.a. | n.a. |
| Q3 2021 | 9 | $2.0bn | n.a. | n.a. |
| Q4 2021 | 8 | $1.6bn | n.a. | n.a. |
| Q1 2022 | 8 | $1.5bn | n.a. | n.a. |
| Q2 2022 | 8 | $1.1bn | n.a. | n.a. |
| Q3 2022 | 6 | $487m | n.a. | n.a. |
| Q4 2022 | 8 | $604m | n.a. | n.a. |
| Q1 2023 | 9 | $502m | n.a. | n.a. |
| Q2 2023 | 11 | $619m | n.a. | n.a. |
| Q3 2023 | 8 | $397m | n.a. | n.a. |
| Q4 2023 | 9 | $593m | 7 | 2 |
| Q1 2024 | 12 | $513m | 7 | 3 |
| Q2 2024 | 13 | $413m | 10 | 2 |
| Q3 2024 | 16 | $809m | 9 | 6 |
| Q4 2024 | 11 | $243m | 7 | 4 |
| Q1 2025 | 8 | $158m | 5 | 3 |
| Q2 2025 | 7 | $120m | 4 | 3 |
| Q3 2025 | 8 | $94m | 3 | 3 |
| Q4 2025 | 5 | $43m | 17 | 17 |
| Q1 2026 | 5 | $48m | 18 | 11 |
| Q2 2026 | 7 | $396m | 11 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
RARE and LLY →RARE and JNJ →RARE and VRTX →Choose a stock to compare with RARE →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own RARE, latest filings →Back to the 13F Explorer →